We observed a significant reduction in cell viability following PSIP1 inhibition, suggesting that PSIP1 is a potential target for therapeutic intervention in ovarian cancer as previously suggested for other cancers [31]. This evidence concerns the gene PSIP1 and ovarian cancer.